Abstract
Extensive studies revealed more than 70 strong candidate regions for susceptibility genes to systemic lupus erythematosus (SLE), and efforts to identify the causative variants in each candidate region are under way. The list of candidate genes points to the crucial pathways that play a role in the development of SLE, such as HLA and immune system signaling, upregulated type I interferon and nucleic acids response, and defective clearance of dying cells. Among these pathways, type I interferon pathway may be particularly relevant to neuropsychiatric SLE (NPSLE), because Aicardi-Goutières syndrome (AGS), a group of single gene diseases with enhanced type I IFN response and exhibits severe central nervous system symptoms, has some similarities with SLE. In fact, variants in some of the genes responsible for AGS are also reported in familial and sporadic patients with SLE. On the other hand, the efforts to identify NPSLE associated genes using case-case association analysis have not been very successful thus far. In the future, large-scale case-case association analysis, not limited to the genes associated with overall SLE, may be necessary in order to identify variants associated with clinical subphenotypes including neuropsychiatric manifestations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alarcon-Segovia D, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005;52:1138–47.
Deapen D, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311–8.
Rees F, et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56:1945–61.
Langefeld CD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8:16021.
Sun C, et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet. 2016;48:323–30.
Morris DL, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet. 2016;48:940–6.
Deng Y, Updates in Lupus Genetics TBP. Curr Rheumatol Rep. 2017;19:68.
Raj P, et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife. 2016; 5. pii: e12089.
Taylor KE, et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 2011;7:e1001311.
Graham RR, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet. 2002;71:543–53.
Furukawa H, et al. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One. 2014;9:e87792.
Sirikong M, et al. Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens. 2002;59:113–7.
Lu LY, et al. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum. 1997;40:1138–45.
Oka S, et al. Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One. 2014;9:e99453.
Kawasaki A, et al. Protective role of HLA-DRB1*13:02 against microscopic Polyangiitis and MPO-ANCA-positive Vasculitides in a Japanese population: a case-control study. PLoS One. 2016;11:e0154393.
Furukawa H, et al. Human leukocyte antigen and systemic sclerosis in Japanese: the sign of the four independent protective alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. PLoS One. 2016;11:e0154255.
Furuya T, et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol. 2004;31:1768–74.
Furukawa H, et al. The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases. Genes Immun. 2017;18:1–7.
Hachiya Y, et al. Association of HLA-G 3' untranslated region polymorphisms with systemic lupus erythematosus in a Japanese population: a case-control association study. PLoS One. 2016;11:e0158065.
Fernando MM, et al. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis. 2012;71:777–84.
Lintner KE, et al. Early components of the complement classical activation pathway in human systemic autoimmune diseases. Front Immunol. 2016;7:36.
Kim K, et al. The HLA-DRbeta1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun. 2014;5:5902.
Bennett L, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197:711–23.
Baechler EC, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003;100:2610–5.
Kawasaki A, et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum. 2008;58:826–34.
Graham RR, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 2007;104:6758–63.
Kawasaki A, et al. TLR7 single-nucleotide polymorphisms in the 3′ untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther. 2011;13:R41.
Shen N, et al. Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2010;107:15838–43.
Cunninghame Graham DS, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 2011;7:e1002341.
Bronson PG, et al. The genetics of type I interferon in systemic lupus erythematosus. Curr Opin Immunol. 2012;24:530–7.
Crow YJ, Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15:429–40.
Cuadrado E, et al. Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies. Ann Rheum Dis. 2015;74:1931–9.
Abe J, et al. A nationwide survey of Aicardi-Goutieres syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study. Rheumatology. 2014;53:448–58.
Shiozawa S, et al. Interferon-alpha in lupus psychosis. Arthritis Rheum. 1992;35:417–22.
Oda H, et al. Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am J Hum Genet. 2014;95:121–5.
Costa-Reis P, Sullivan KE. Monogenic lupus: it's all new. Curr Opin Immunol. 2017;49:87–95.
Ellyard JI, et al. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by whole-exome sequencing. Arthritis Rheumatol. 2014;66:3382–6.
de Vries B, et al. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis. 2010;69:1886–7.
Lee-Kirsch MA, et al. Mutations in the gene encoding the 3′-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007;39:1065–7.
Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol. 2017;185:59–73.
Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7:55.
Sisirak V, et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell. 2016;166:88–101.
Yasutomo K, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet. 2001;28:313–4.
Graham RR, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40:1059–61.
Kawasaki A, et al. Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther. 2010;12:R174.
Sandling JK, Garnier S, Sigurdsson S, Wang C, Nordmark G, Gunnarsson I, et al. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur J Hum Genet. 2011;1(9):479–84.
Lewis MJ, et al. UBE2L3 polymorphism amplifies NF-kappaB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221–34.
Wu YY, et al. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels. J Immunol. 2015;194:5692–702.
Samuelson EM, et al. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice. PLoS One. 2014;9:e92054.
Ito I, et al. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum. 2009;60:553–8.
Hom G, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9.
Kawasaki A, et al. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res Ther. 2008;10:R113.
Zhao J, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49:433–7.
Fredi M, et al. Typing TREX1 gene in patients with systemic lupus erythematosus. Reumatismo. 2015;67:1–7.
Ho RC, et al. Genetic variants that are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2016;43:541–51.
Ota Y, et al. Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus. Mod Rheumatol. 2010;20:427–31.
Pullmann R Jr, et al. Apolipoprotein E polymorphism in patients with neuropsychiatric SLE. Clin Rheumatol. 2004;23:97–101.
Ruiz-Larranaga O, et al. Genetic association study of systemic lupus erythematosus and disease subphenotypes in European populations. Clin Rheumatol. 2016;35:1161–8.
Taha S, et al. Vascular endothelial growth factor G1612A (rs10434) gene polymorphism and neuropsychiatric manifestations in systemic lupus erythematosus patients. Rev Bras Reumatol Engl Ed. 2017;57:149–53.
Ramirez GA, et al. TRPC6 gene variants and neuropsychiatric lupus. J Neuroimmunol. 2015;288:21–4.
Sandrin-Garcia P, et al. Functional single-nucleotide polymorphisms in the DEFB1 gene are associated with systemic lupus erythematosus in southern Brazilians. Lupus. 2012;21:625–31.
Kisiel BM, et al. Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta. Lupus. 2011;20:85–9.
Yang W, et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet. 2009;18:2063–70.
Bassi C, et al. Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus. Lupus. 2008;17:988–95.
Oroszi G, et al. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis. 2006;65:1330–5.
Liao CH, et al. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol. 2004;31:2062–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Tsuchiya, N. (2018). Genetics. In: Hirohata, S. (eds) Neuropsychiatric Systemic Lupus Erythematosus. Springer, Cham. https://doi.org/10.1007/978-3-319-76496-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-76496-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76495-5
Online ISBN: 978-3-319-76496-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)